Q1 2026 Holdings
Filed 2026-05-15 | 56 holdings | $193.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Compass Therapeutics IncCall | CALL | 20454B904 | $132.8K | 25,100 | 0.1% |
| Wave Life Sciences LTDPut | PUT | Y95308955 | $217.5K | 30,000 | 0.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $339.7K | 75,484 | 0.2% |
| Lipocine Inc New(LPCN) | COM NEW | 53630X203 | $486.3K | 60,861 | 0.3% |
| Travere Therapeutics IncPut | PUT | 89422G957 | $594.2K | 20,000 | 0.3% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $743.8K | 13,100 | 0.4% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $1.1M | 600,000 | 0.5% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $1.2M | 115,500 | 0.6% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $1.2M | 130,564 | 0.6% |
| Ideaya Biosciences IncPut | CALL | 45166A902 | $1.3M | 40,000 | 0.7% |
| Ideaya Biosciences IncCall | CALL | 45166A902 | $1.3M | 40,000 | 0.7% |
| Centessa Pharmaceuticals PLCPut | PUT | 152309950 | $1.4M | 34,700 | 0.7% |
| Novabridge Biosciences(NBP) | SPONSORED ADS | 44975P103 | $1.4M | 576,960 | 0.7% |
| Liquidia CorporationPut | PUT | 53635D952 | $1.5M | 40,000 | 0.8% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $1.6M | 80,730 | 0.8% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.7M | 45,796 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $2.1M | 61,673 | 1.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $2.1M | 6,300 | 1.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $2.2M | 234,136 | 1.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $2.2M | 20,874 | 1.2% |
| Alumis IncPut | PUT | 022307952 | $2.3M | 105,000 | 1.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.4M | 159,341 | 1.2% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $2.5M | 521,468 | 1.3% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $2.6M | 88,510 | 1.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.8M | 278,302 | 1.4% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $2.8M | 153,191 | 1.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $2.9M | 45,721 | 1.5% |
| Adagene Inc(ADAG) | ADS | 005329107 | $2.9M | 736,845 | 1.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.9M | 6,358 | 1.5% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.0M | 179,484 | 1.5% |
| Beone Medicines LTDCall | CALL | 07725L902 | $3.0M | 10,000 | 1.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.0M | 84,103 | 1.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $3.0M | 48,347 | 1.6% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $3.3M | 154,194 | 1.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $3.4M | 636,700 | 1.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $3.4M | 85,517 | 1.8% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $3.5M | 12,862 | 1.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $3.5M | 40,581 | 1.8% |
| Natera Inc(NTRA) | COM | 632307104 | $3.7M | 18,650 | 1.9% |
| Cytokinetics IncPut | PUT | 23282W955 | $4.0M | 60,000 | 2.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.0M | 215,376 | 2.1% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $4.2M | 7,053 | 2.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $4.2M | 125,060 | 2.2% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $4.3M | 14,677 | 2.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.4M | 26,651 | 2.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $4.6M | 114,991 | 2.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.0M | 67,492 | 2.6% |
| Alumis Inc(ALMS) | COM | 022307102 | $6.2M | 279,176 | 3.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.4M | 7,012 | 3.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.8M | 103,718 | 3.5% |